Privately-held cell therapy company Orca Bio has announced that the US Food and Drug Administration (FDA) has accepted for ...

Massachusetts, USA-based Affinia Therapeutics, an innovative gene therapy company with a pipeline of first-in-class and/or ...

US biotech AeroRx Therapeutics has secured $21 million in Series A financing to advance its lead program, AERO-007, into ...

The ground shifted under China’s drugmakers when volume-based procurement cut through list prices. Margins tightened, ...

Dutch biotech uniQure recently announced that its novel gene therapy, AMT-130 (ifezuntirgene inilparvovec), demonstrated ...

Australian biotech Neurizon Therapeutics (ASX: NUZ) said the US regulator has lifted the clinical hold on its lead drug ...

Skye Bioscience (Nasdaq: SKYE) reported topline data from a mid-stage trial showing that its obesity drug nimacimab failed to ...

UK-based developer of novel immunoglobulin E (IgE) antibodies to treat cancer, Epsilogen, today announced the appointment of ...

Belgian biotech Bioxodes has appointed Philippe Monteyne as chairman of its board, replacing Pierre Detrixhe. The move comes ...

US lobby group Pharmaceutical Research and Manufacturers of America (PhRMA) revealed that member companies, thanks to ...

The atrial fibrillation (AF) market across the eight major markets (8MM) is forecast to decline at a negative compound annual ...

Oxford, UK-based clinical-stage biotech Theolytics today announced the appointment of Dr Matilde Saggese, as chief medical ...